Good post on “Endocrinology Network” news, summarizing of research and trends regarding T3-based thyroid medication prescriptions for hypothyroidism around the world (not mentioning Canada, though). Fuerst, M. (2019, February 14). Physician–patient interaction may influence prescribing patterns in hypothyroidism | Endocrinology… Read More ›
Are you a thyroid warrior? Can you speak of years lost to hypo or hyper symptoms — either your own or a family member’s or friend’s? Will you speak up for those too fatigued to self-advocate? Will you join the… Read More ›
Our thyroid patient campaign’s researcher submitted a proposal to speak at the Choosing Wisely national conference in Montreal in May 2019. A second thyroid patient was willing to fund the researcher’s trip from Western Canada. A third thyroid patient put… Read More ›
On Valentine’s Day, we thyroid patients send out a big thank you to our supporters. We need people to lean on, to listen, to support us in hard times.
In the “Dirty Money” series on Netflix, the “Drug Short” episode (1) helped me understand some of the economic forces that may have influenced T3 / Liothyronine price hikes in the UK. It makes me concerned about the future of… Read More ›
The American Thyroid Association prolongs the suffering of patients with autoimmune thyroid damage whose TSH has not yet risen to >10 mIU/L or their Free T4 has not yet fallen below reference. (1, 2) As I will outline in this… Read More ›
WISH LIST: What our campaign needs (updated February 1. 2019) • Reviews and likes on our Facebook Page at https://www.facebook.com/thyroidpatients.ca/ , 2-way discussion in our public FB Group where you can also add posts, and your engagement in post likes/responses, post shares,… Read More ›
We hypothyroid patients on thyroid therapy have an argument to make about one of the secretions of the pituitary gland, the TSH. But you won’t let us speak. You have put the TSH in charge of monitoring our thyroid hormone… Read More ›